Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $14 | $14 | $16 | $10 |
| Short-Term Investments | $3 | $2 | $1 | $4 |
| Receivables | $9 | $10 | $8 | $6 |
| Inventory | $7 | $8 | $7 | $5 |
| Other Curr. Assets | $2 | $1 | $6 | $2 |
| Total Curr. Assets | $34 | $34 | $35 | $30 |
| Property Plant & Equip (Net) | $23 | $24 | $16 | $13 |
| Goodwill | $11 | $11 | $10 | $9 |
| Intangibles | $19 | $18 | $16 | $13 |
| Long-Term Investments | $23 | $26 | $25 | $20 |
| Tax Assets | $1 | $1 | $0 | $0 |
| Other NC Assets | $5 | $0 | $5 | $7 |
| Total NC Assets | $83 | $80 | $72 | $63 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $117 | $113 | $107 | $93 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $6 | $5 |
| Short-Term Debt | $19 | $15 | $12 | $15 |
| Tax Payable | $1 | $0 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $2 | $8 |
| Other Curr. Liab. | $12 | $13 | $14 | $8 |
| Total Curr. Liab. | $37 | $34 | $33 | $29 |
| LT Debt | $13 | $16 | $13 | $10 |
| Deferred Rev, NC | $1 | $0 | $1 | $1 |
| Deferred Tax Liab, NC | $3 | $0 | $3 | $3 |
| Other NC Liab. | $3 | $8 | $3 | $2 |
| Total NC Liab. | $20 | $23 | $20 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $2 | $1 | $1 |
| Total Liabilities | $58 | $57 | $53 | $45 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | $27 | $25 | $26 | $21 |
| AOCI | $0 | -$1 | -$1 | $4 |
| Other Equity | $18 | $20 | $17 | $11 |
| Total Equity | $47 | $46 | $45 | $39 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $13 | $11 | $10 | $9 |
| Total Liab. & Tot. Equity | $117 | $113 | $107 | $93 |
| Net Debt | $18 | $17 | $9 | $14 |